Cargando…
Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue
BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997924/ https://www.ncbi.nlm.nih.gov/pubmed/36848385 http://dx.doi.org/10.1371/journal.pntd.0010750 |
_version_ | 1784903361089241088 |
---|---|
author | Bernal, Cynthia Ping, Sara Rojas, Alejandra Caballero, Oliver Stittleburg, Victoria de Guillén, Yvalena Langjahr, Patricia Pinsky, Benjamin A. Von-Horoch, Marta Luraschi, Patricia Cabral, Sandra Sánchez, María Cecilia Torres, Aurelia Cardozo, Fátima Waggoner, Jesse J. |
author_facet | Bernal, Cynthia Ping, Sara Rojas, Alejandra Caballero, Oliver Stittleburg, Victoria de Guillén, Yvalena Langjahr, Patricia Pinsky, Benjamin A. Von-Horoch, Marta Luraschi, Patricia Cabral, Sandra Sánchez, María Cecilia Torres, Aurelia Cardozo, Fátima Waggoner, Jesse J. |
author_sort | Bernal, Cynthia |
collection | PubMed |
description | BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL FINDINGS: One hundred forty-five confirmed dengue cases (median age, 42; range <1–91 years), enrolled from February 2018 to March 2020, were selected from an ongoing study of suspected arboviral infections in metropolitan Asunción, Paraguay. Cases included dengue virus types 1, 2, and 4, and severity was categorized according to the 2009 World Health Organization guidelines. Testing for anti-dengue virus IgM and IgG and serum biomarkers (lipopolysaccharide binding protein and chymase) was performed on acute-phase sera in plate-based ELISAs; in addition, a multiplex ELISA platform was used to measure anti-dengue virus and anti-Zika virus IgM and IgG. Complete blood counts and chemistries were performed at the discretion of the care team. Age, gender, and pre-existing comorbidities were associated with SD vs. dengue with/without warning signs in logistic regression with odds ratios (ORs) of 1.07 (per year; 95% confidence interval, 1.03, 1.11), 0.20 (female; 0.05,0.77), and 2.09 (presence; 1.26, 3.48) respectively. In binary logistic regression, for every unit increase in anti-DENV IgG in the multiplex platform, odds of SD increased by 2.54 (1.19–5.42). Platelet count, lymphocyte percent, and elevated chymase were associated with SD in a combined logistic regression model with ORs of 0.99 (1,000/μL; 0.98,0.999), 0.92 (%; 0.86,0.98), and 1.17 (mg/mL; 1.03,1.33) respectively. CONCLUSIONS: Multiple, readily available factors were associated with SD in this population. These findings will aid in the early detection of potentially severe dengue cases and inform the development of new prognostics for use in acute-phase and serial samples from dengue cases. |
format | Online Article Text |
id | pubmed-9997924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-99979242023-03-10 Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue Bernal, Cynthia Ping, Sara Rojas, Alejandra Caballero, Oliver Stittleburg, Victoria de Guillén, Yvalena Langjahr, Patricia Pinsky, Benjamin A. Von-Horoch, Marta Luraschi, Patricia Cabral, Sandra Sánchez, María Cecilia Torres, Aurelia Cardozo, Fátima Waggoner, Jesse J. PLoS Negl Trop Dis Research Article BACKGROUND: Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of severe disease to improve outcomes and judiciously utilize resources. METHODS/PRINCIPAL FINDINGS: One hundred forty-five confirmed dengue cases (median age, 42; range <1–91 years), enrolled from February 2018 to March 2020, were selected from an ongoing study of suspected arboviral infections in metropolitan Asunción, Paraguay. Cases included dengue virus types 1, 2, and 4, and severity was categorized according to the 2009 World Health Organization guidelines. Testing for anti-dengue virus IgM and IgG and serum biomarkers (lipopolysaccharide binding protein and chymase) was performed on acute-phase sera in plate-based ELISAs; in addition, a multiplex ELISA platform was used to measure anti-dengue virus and anti-Zika virus IgM and IgG. Complete blood counts and chemistries were performed at the discretion of the care team. Age, gender, and pre-existing comorbidities were associated with SD vs. dengue with/without warning signs in logistic regression with odds ratios (ORs) of 1.07 (per year; 95% confidence interval, 1.03, 1.11), 0.20 (female; 0.05,0.77), and 2.09 (presence; 1.26, 3.48) respectively. In binary logistic regression, for every unit increase in anti-DENV IgG in the multiplex platform, odds of SD increased by 2.54 (1.19–5.42). Platelet count, lymphocyte percent, and elevated chymase were associated with SD in a combined logistic regression model with ORs of 0.99 (1,000/μL; 0.98,0.999), 0.92 (%; 0.86,0.98), and 1.17 (mg/mL; 1.03,1.33) respectively. CONCLUSIONS: Multiple, readily available factors were associated with SD in this population. These findings will aid in the early detection of potentially severe dengue cases and inform the development of new prognostics for use in acute-phase and serial samples from dengue cases. Public Library of Science 2023-02-27 /pmc/articles/PMC9997924/ /pubmed/36848385 http://dx.doi.org/10.1371/journal.pntd.0010750 Text en © 2023 Bernal et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Bernal, Cynthia Ping, Sara Rojas, Alejandra Caballero, Oliver Stittleburg, Victoria de Guillén, Yvalena Langjahr, Patricia Pinsky, Benjamin A. Von-Horoch, Marta Luraschi, Patricia Cabral, Sandra Sánchez, María Cecilia Torres, Aurelia Cardozo, Fátima Waggoner, Jesse J. Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title | Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title_full | Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title_fullStr | Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title_full_unstemmed | Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title_short | Serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
title_sort | serum biomarkers and anti-flavivirus antibodies at presentation as indicators of severe dengue |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997924/ https://www.ncbi.nlm.nih.gov/pubmed/36848385 http://dx.doi.org/10.1371/journal.pntd.0010750 |
work_keys_str_mv | AT bernalcynthia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT pingsara serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT rojasalejandra serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT caballerooliver serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT stittleburgvictoria serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT deguillenyvalena serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT langjahrpatricia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT pinskybenjamina serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT vonhorochmarta serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT luraschipatricia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT cabralsandra serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT sanchezmariacecilia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT torresaurelia serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT cardozofatima serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue AT waggonerjessej serumbiomarkersandantiflavivirusantibodiesatpresentationasindicatorsofseveredengue |